Coronary Artery Calcification and Plaque Characteristics in People Living With HIV: A Systematic Review and

Cullen Soares1, Amjad Samara2, Matthew F Yuyun3,4,5

  • 1Department of Medicine University of Maryland Baltimore MD.

Insights

People living with HIV have a higher prevalence of noncalcified coronary plaques but similar coronary artery calcium compared to HIV-negative individuals. Further research on plaque progression is needed to understand subclinical atherosclerosis in this population.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Individuals with HIV often exhibit a greater burden of subclinical cardiovascular disease.
  • Existing data on cardiovascular disease in people with HIV require comprehensive synthesis.
  • Coronary artery calcium and plaque prevalence studies in HIV-positive individuals need meta-analysis.

Purpose of the Study:

  • To synthesize data on coronary artery calcium and coronary plaque in people living with HIV through meta-analyses.
  • To compare the prevalence and progression of subclinical atherosclerosis between HIV-positive and HIV-negative individuals.
  • To identify factors influencing cardiovascular disease burden in the HIV population.

Main Methods:

  • Systematic literature search across electronic databases.
  • Data abstraction using standardized forms from 43 reports (27 unique studies).
  • Meta-analysis of pooled estimates from 10,867 participants (6,699 HIV-positive, 4,168 HIV-negative).

Main Results:

  • Similar prevalence of coronary artery calcium (>0) between HIV-positive (45%) and HIV-negative (52%) individuals, which became non-significant after adjusting for Framingham Risk Score.
  • Higher prevalence of noncalcified plaque in HIV-positive (49%) versus HIV-negative (20%) participants (OR 1.23, 95% CI 1.08-1.38).
  • HIV-positive participants were younger and had lower Framingham Risk Scores than HIV-negative participants.

Conclusions:

  • People living with HIV have a significantly higher prevalence of noncalcified coronary plaques.
  • The prevalence of coronary artery calcium is similar between HIV-positive and HIV-negative individuals.
  • Further studies on coronary artery calcium and plaque progression are essential to fully understand subclinical atherosclerosis in people living with HIV.

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
161
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
502
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
84
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
401
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
78
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
184